Showing results (11-20 of 252) with videos related to
Sort By:
Pageof 26
Molecular Pharmacology|January 1, 1982
Heat treatment mimics guanosine-5'-triphosphate effects on dopaminergic 3H-ligand binding to bovine caudate membranesM W Hamblin, I CreeseLife Sciences|May 3, 1982
3H-dopamine binding to rat striatal D-2 and D-3 sites: enhancement by magnesium and inhibition by guanine nucleotides and sodiumM W Hamblin, I CreeseNature|December 8, 1983
Dopaminergic D-3 binding sites are not presynaptic autoreceptorsS E Leff, I CreeseLife Sciences|May 9, 1983
Behavioral and radioligand binding evidence for irreversible dopamine receptor blockade by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinolineM W Hamblin, I CreeseMolecular Pharmacology|May 1, 1983
Interactions of ergot alkaloids with anterior pituitary D-2 dopamine receptorsD R Sibley, I CreeseEuropean Journal of Pharmacology|June 15, 1979
Nigrostriatal lesions enhance striatal 3H-apomorphine and 3H-spiroperidol bindingI Creese, S H SnyderMolecular Pharmacology|July 1, 1989
Comparison of two putatively selective radioligands for labeling central nervous system beta-adrenergic receptors: inadequacy of [3H]dihydroalprenololM A Riva, I CreeseMolecular Pharmacology|July 1, 1989
Reevaluation of the regulation of beta-adrenergic receptor binding by desipramine treatmentM A Riva, I CreeseMolecular Pharmacology|February 1, 1985
Interactions of dopaminergic agonists and antagonists with dopaminergic D3 binding sites in rat striatum. Evidence that [3H]dopamine can label a high affinity agonist-binding state of the D1 dopamine receptorS E Leff, I CreeseCiba Foundation Symposium|January 1, 1982
Behavioural effects of substance P through dopaminergic pathways in the brainS D IversenPageof 26